Advances in Precision Medicine NGS Testing, and Breaking the Barriers with Clinical Trials
Friday, May 12, 2023
5pm ET/ 2pm PT
Targeted therapies are a type of cancer treatment that targets proteins that control how cancer cells grow, divide, and spread. They are the foundation of precision medicine. As researchers learn more about the DNA changes and proteins that drive cancer, they are better able to design treatments that target these proteins. The purpose of this webinar is to provide an overview of current research of targeted therapies as demonstrated by the efforts of Endeavor Biomedicines; and hear from Oncology Nurses about what barriers they are seeing in the clinic.
This webinar is open to anyone interested in attending. We encourage Oncology Nurses, Navigation Nurses, Genetic Counselors, Oncologists, Patient Advocates / Caregivers and Patients to attend.
SPEAKERS
John Hood
Chief Executive Officer,
Endeavor Biomedicines
Dellann Elliott Mydland
President & Chair,
End Brain Cancer Initiative
Anita DiFrancesco
VP, Clinical Operations, Endeavor BioMedicines
